Ellen O'Connor Vos is Director at OptimizeRx Corp (OPRX). They have made 7 open-market trades across 3 companies since 2017, most recently 2026-06-09.
CIK 0001534357
7 open-market purchases totalling $378K since 2017, never a sale. Across 7 scored buys the stock is up 42.1% at ninety days, and 38.2 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 57% | 43% | 71% |
| Avg Move | +0.2% | +5.5% | +42.1% |
| Alpha | -2.4% | +4.5% | +38.2% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AWH | BUY | 2023-07-24 | 2023-07-26 | $3.98 | $15K | +14.3% | +40.4% | +119.2% |
| OPRX | BUY | 2022-08-16 | 2022-08-17 | $15.91 | $8K | -1.9% | -6.7% | +38.7% |
| MODD | BUY | 2021-10-28 | 2021-11-01 | $2.70 | $300K | -31.3% | -10.6% | -10.6% |
| OPRX | BUY | 2020-03-31 | 2020-04-01 | $8.75 | $9K | +4.9% | +8.6% | +51.5% |
| OPRX | BUY | 2019-11-13 | 2019-11-14 | $9.62 | $6K | +9.6% | +0.0% | +14.1% |
| OPRX | BUY | 2018-06-22 | 2018-06-27 | $10.47 | $19K | +7.4% | +7.4% | +82.8% |
| OPRX | BUY | 2017-02-06 | 2017-05-31 | $0.78 | $22K | -1.4% | -1.0% | -1.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.